MicroRNAs in atherosclerosis

Journal of Vascular Research

Volumn 51, Issue 5, 2014, Pages 338-349

  Hosin, Ali A ^a   Prasad, Anoop ^a   Viiri, Leena E ^b   Davies, Alun H ^a   Shalhoub, Joseph ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Atherosclerosis; Cardiovascular disease; Metabolism; MicroRNA; Vascular smooth muscle cells

Indexed keywords

CELL ADHESION MOLECULE; MICRORNA; OXIDIZED LOW DENSITY LIPOPROTEIN;

ADAPTIVE IMMUNITY; ANGIOGENESIS; ARTERY DISEASE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLULAR STRESS RESPONSE; CHOLESTEROL HOMEOSTASIS; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE PREDISPOSITION; DOWN REGULATION; ENDOTHELIUM CELL; GENE SWITCHING; HOMEOSTASIS; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; RNA ANALYSIS; SENESCENCE; SHEAR STRESS; VASCULAR SMOOTH MUSCLE; ANIMAL; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHENOTYPE; RISK FACTOR; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ANIMALS; ATHEROSCLEROSIS; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENETIC THERAPY; HUMANS; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; PHENOTYPE; PROGNOSIS; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 84917705795     PISSN: 10181172     EISSN: 14230135     Source Type: Journal    
DOI: 10.1159/000368193     Document Type: Review

References (125)

1. Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-1695.
2. Shalhoub J, et al: Innate immunity and monocyte-macrophage activation in atherosclerosis. J Inflamm 2011; 8: 9.
3. Lee RC, Feinbaum RL, Ambros V: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75: 843-854.
4. Lagos-Quintana M, et al: Identification of novel genes coding for small expressed RNAs. Science 2001; 294: 853-858.
5. Lau NC, et al: An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans . Science 2001; 294: 858-862.
6. Lee RC, Ambros V: An extensive class of small RNAs in Caenorhabditis elegans . Science 2001; 294: 862-864.
7. Lewis BP, Burge CB, Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20.
8. Moher D, et al: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
9. Vanhoutte PM: Endothelial dysfunction and atherosclerosis. Eur Heart J 1997; 18(suppl E): E19-E29.
10. Michiels C: Endothelial cell functions. J Cell Physiol 2003; 196: 430-443.
11. Ross R: Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340: 115-126.
12. Dai G, et al: Distinct endothelial phenotypes evoked by arterial waveforms derived from atherosclerosis-susceptible and-resistant regions of human vasculature. Proc Natl Acad Sci U S A 2004; 101: 14871-14876.
13. Ku DN, et al: Pulsatile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low oscillating shear stress. Arteriosclerosis 1985; 5: 293-302.
14. Dekker RJ, et al: Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Kruppel-like factor (KLF2). Blood 2002; 100: 1689-1698.
15. Parmar KM, et al: Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2. J Clin Invest 2006; 116: 49-58.
16. Atkins GB, Jain MK: Role of Kruppel-like transcription factors in endothelial biology. Circ Res 2007; 100: 1686-1695.
17. Lan Q, Mercurius KO, Davies PF: Stimulation of transcription factors NF kappa B and AP1 in endothelial cells subjected to shear stress. Biochem Biophys Res Commun 1994; 201: 950-956.
18. Fang Y, et al: MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro. Proc Natl Acad Sci U S A 2010; 107: 13450-13455.
19. Qin X, et al: MicroRNA-19a mediates the suppressive effect of laminar flow on cyclin D1 expression in human umbilical vein endothelial cells. Proc Natl Acad Sci U S A 2010; 107: 3240-3244.
20. Malek AM, Alper SL, Izumo S: Hemodynamic shear stress and its role in atherosclerosis. JAMA 1999; 282: 2035-2042.
21. Cheng C, et al: Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress. Circulation 2006; 113: 2744-2753.
22. Harris TA, et al: MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci U S A 2008; 105: 1516-1521.
23. Suarez Y, et al: Cutting edge: TNF-induced microRNAs regulate TNF-induced expression of E-selectin and intercellular adhesion molecule-1 on human endothelial cells: feedback control of inflammation. J Immunol 2010; 184: 21-25.
24. Chien S, Li S, Shyy YJ: Effects of mechanical forces on signal transduction and gene expression in endothelial cells. Hypertension 1998; 31: 162-169.
25. Li YS, Haga JH, Chien S: Molecular basis of the effects of shear stress on vascular endothelial cells. J Biomech 2005; 38: 1949-1971.
26. Weber M, et al: MiR-21 is induced in endothelial cells by shear stress and modulates apoptosis and eNOS activity. Biochem Biophys Res Commun 2010; 393: 643-648.
27. Ni CW, Qiu H, Jo H: MicroRNA-663 upregulated by oscillatory shear stress plays a role in inflammatory response of endothelial cells. Am J Physiol Heart Circ Physiol 2011; 300: H1762-H1769.
28. Son DJ, et al: The atypical mechanosensitive microRNA-712 derived from pre-ribosomal RNA induces endothelial inflammation and atherosclerosis. Nat Commun 2013; 4: 3000.
29. Wu Y, et al: MiR-152 reduces human umbilical vein endothelial cell proliferation and migration by targeting ADAM17. FEBS Lett 2014; 588: 2063-2069.
30. Zampetaki A, Kirton JP, Xu Q: Vascular repair by endothelial progenitor cells. Cardiovasc Res 2008; 78:413-421.
31. Minami Y, et al: Effect of atorvastatin on microRNA 221/222 expression in endothelial progenitor cells obtained from patients with coronary artery disease. Eur J Clin Invest 2009; 39: 359-367.
32. Dimmeler S, et al: HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 2001; 108: 391-397.
33. Rivard A, Andres V: Vascular smooth muscle cell proliferation in the pathogenesis of atherosclerotic cardiovascular diseases. Histol Histopathol 2000; 15: 557-571.
34. Prokopi M, et al: Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Blood 2009; 114: 723-732.
35. Damas JK, et al: Stromal cell-derived factor-1alpha in unstable angina: potential antiinflammatory and matrix-stabilizing effects. Circulation 2002; 106: 36-42.
36. Zernecke A, et al: Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2009; 2: ra81.
37. Tan KS, et al: Expression profile of micro-RNAs in young stroke patients. PLoS One 2009; 4:e7689.
38. Menghini R, et al: MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation 2009; 120: 1524-1532.
39. Vasa-Nicotera M, et al: miR-146a is modulated in human endothelial cells with aging. Atherosclerosis 2011; 217: 326-330.
40. Cheng HS, et al: MicroRNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways. EMBO Mol Med 2013; 5: 949-966.
41. Packard RR, Libby P: Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem 2008; 54: 24-38.
42. Koenig W, Khuseyinova N: Biomarkers of atherosclerotic plaque instability and rupture. Arterioscler Thromb Vasc Biol 2007; 27: 15-26.
43. Dunmore BJ, et al: Carotid plaque instability and ischemic symptoms are linked to immaturity of microvessels within plaques. J Vasc Surg 2007; 45: 155-159.
44. Kane NM, et al: MicroRNAs as modulators of stem cells and angiogenesis. Stem Cells 2014; 32: 1059-1066.
45. Chen JF, et al: Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proc Natl Acad Sci U S A 2008; 105: 2111-2116.
46. Yang WJ, et al: Dicer is required for embryonic angiogenesis during mouse development. J Biol Chem 2005; 280: 9330-9335.
47. Suarez Y, et al: Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ Res 2007; 100: 1164-1173.
48. Suarez Y, et al: Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proc Natl Acad Sci U S A 2008; 105: 14082-14087.
49. Wang S, Olson EN: AngiomiRs-key regulators of angiogenesis. Curr Opin Genet Dev 2009; 19: 205-211.
50. Dentelli P, et al: microRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression. Arterioscler Thromb Vasc Biol 2010; 30: 1562-1568.
51. Fasanaro P, et al: MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem 2008; 283: 15878-15883.
52. Kuijper S, Turner CJ, Adams RH: Regulation of angiogenesis by Eph-ephrin interactions. Trends Cardiovasc Med 2007; 17: 145-151.
53. Haver VG, et al: Rupture of vulnerable atherosclerotic plaques: microRNAs conducting the orchestra? Trends Cardiovasc Med 2010; 20: 65-71.
54. Chen T, et al: MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte/macrophages. Cardiovasc Res 2009; 83: 131-139.
55. Olkkonen VM: Oxysterol binding protein and its homologues: new regulatory factors involved in lipid metabolism. Curr Opin Lipidol 2004; 15: 321-327.
56. Mango R, et al: In vivo and in vitro studies support that a new splicing isoform of OLR1 gene is protective against acute myocardial infarction. Circ Res 2005; 97: 152-158.
57. Hao L, et al: The up-regulation of endothelin-1 and down-regulation of miRNA-125a-5p,-155, and-199a/b-3p in human atherosclerotic coronary artery. Cardiovasc Pathol 2014; 23: 217-223.
58. Thulin P, et al: MicroRNA-9 regulates the expression of peroxisome proliferator-activated receptor delta in human monocytes during the inflammatory response. Int J Mol Med 2013; 31: 1003-1010.
59. Xu J, et al: MiR-9 reduces human acyl-coenzyme A:cholesterol acyltransferase-1 to decrease THP-1 macrophage-derived foam cell formation. Acta Biochim Biophys Sin 2013; 45: 953-962.
60. Huang RS, et al: MicroRNA-155 silencing enhances inflammatory response and lipid uptake in oxidized low-density lipoproteinstimulated human THP-1 macrophages. J Investig Med 2010; 58: 961-967.
61. Zhu GF, et al: miR-155 inhibits oxidized lowdensity lipoprotein-induced apoptosis of RAW264.7 cells. Mol Cell Biochem 2013; 382: 253-261.
62. Tang B, et al: Identification of MyD88 as a novel target of miR-155, involved in negative regulation of Helicobacter pylori-induced inflammation. FEBS Lett 2010; 584: 1481-1486.
63. Tian FJ, et al: Elevated microRNA-155 promotes foam cell formation by targeting HBP1 in atherogenesis. Cardiovasc Res 2014; 103: 100-110.
64. Satoh M, et al: Immune modulation: role of the inflammatory cytokine cascade in the failing human heart. Curr Heart Fail Rep 2008; 5: 69-74.
65. Cole JE, Georgiou E, Monaco C: The expression and functions of Toll-like receptors in atherosclerosis. Mediators Inflamm 2010; 2010: 393946.
66. Cole JE, Mitra AT, Monaco C: Treating atherosclerosis: the potential of Toll-like receptors as therapeutic targets. Expert Rev Cardiovasc Ther 2010; 8: 1619-1635.
67. Ishikawa Y, et al: Local expression of Toll-like receptor 4 at the site of ruptured plaques in patients with acute myocardial infarction. Clin Sci (Lond) 2008; 115: 133-140.
68. Owens GK: Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 1995; 75: 487-517.
69. Owens GK, Kumar MS, Wamhoff BR: Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 2004; 84: 767-801.
70. Yoshida T, Owens GK: Molecular determinants of vascular smooth muscle cell diversity. Circ Res 2005; 96: 280-291.
71. Sobue K, Hayashi K, Nishida W: Expressional regulation of smooth muscle cell-specific genes in association with phenotypic modulation. Mol Cell Biochem 1999; 190: 105-118.
72. Cordes KR, et al: miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009; 460: 705-710.
73. Hu B, et al: Mechanical stretch suppresses microRNA-145 expression by activating extracellular signal-regulated kinase 1/2 and upregulating angiotensin-converting enzyme to alter vascular smooth muscle cell phenotype. PLoS One 2014; 9:e96338.
74. Boettger T, et al: Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J Clin Invest 2009; 119: 2634-2647.
75. Gimona M, et al: Calponin repeats regulate actin filament stability and formation of podosomes in smooth muscle cells. Mol Biol Cell 2003; 14: 2482-2491.
76. Quintavalle M, et al: MicroRNA control of podosome formation in vascular smooth muscle cells in vivo and in vitro. J Cell Biol 2010; 189: 13-22.
77. Torella D, et al: MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo. Circ Res 2011; 109: 880-893.
78. Kavurma MM, Khachigian LM: Sp1 inhibits proliferation and induces apoptosis in vascular smooth muscle cells by repressing p21WAF1/Cip1 transcription and cyclin D1-Cdk4-p21WAF1/Cip1 complex formation. J Biol Chem 2003; 278: 32537-32543.
79. Muto A, et al: Smooth muscle cell signal transduction: implications of vascular biology for vascular surgeons. J Vasc Surg 2007; 45(suppl A): A15-A24.
80. Ji R, et al: MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res 2007; 100: 1579-1588.
81. Liu X, et al: A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 2009; 104: 476-487.
82. Liu X, et al: Cell-specific effects of miR-221/222 in vessels: molecular mechanism and therapeutic application. J Mol Cell Cardiol 2012; 52: 245-255.
83. Davis BN, et al: Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. J Biol Chem 2009; 284: 3728-3738.
84. Andrae J, Gallini R, Betsholtz C: Role of platelet-derived growth factors in physiology and medicine. Genes Dev 2008; 22: 1276-1312.
85. Wang Z, et al: Myocardin is a master regulator of smooth muscle gene expression. Proc Natl Acad Sci U S A 2003; 100: 7129-7134.
86. Tang RH, et al: Myocardin inhibits cellular proliferation by inhibiting NF-kappaB(p65)-dependent cell cycle progression. Proc Natl Acad Sci U S A 2008; 105: 3362-3367.
87. Chen J, et al: Induction of microRNA-1 by myocardin in smooth muscle cells inhibits cell proliferation. Arterioscler Thromb Vasc Biol 2011; 31: 368-375.
88. Katakami N, et al: Role of pim-1 in smooth muscle cell proliferation. J Biol Chem 2004; 279: 54742-54749.
89. Leeper NJ, et al: MicroRNA-26a is a novel regulator of vascular smooth muscle cell function. J Cell Physiol 2011; 226: 1035-1043.
90. Kim MH, et al: MicroRNA-365 inhibits the proliferation of vascular smooth muscle cells by targeting cyclin D1. J Cell Biochem 2014; 115: 1752-1761.
91. Esau C, et al: miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 2006; 3: 87-98.
92. Krutzfeldt J, et al: Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005; 438: 685-689.
93. Ng R, et al: Inhibition of microRNA-24 expression in liver prevents hepatic lipid accumulation and hyperlipidemia. Hepatology 2014; 60: 554-564.
94. Elmen J, et al: LNA-mediated microRNA silencing in non-human primates. Nature 2008; 452: 896-899.
95. Yang M, et al: Identification of miR-185 as a regulator of de novo cholesterol biosynthesis and low-density lipoprotein uptake. J Lipid Res 2014; 55: 226-238.
96. Rayner KJ, et al: MiR-33 contributes to the regulation of cholesterol homeostasis. Science 2010; 328: 1570-1573.
97. Oram JF, Vaughan AM: ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins. Curr Opin Lipidol 2000; 11: 253-260.
98. Tall AR, et al: HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis. Cell Metab 2008; 7: 365-375.
99. Horie T, et al: MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice. Nat Commun 2013; 4: 2883.
100. Hu YW, et al: An agomir of miR-144-3p accelerates plaque formation through impairing reverse cholesterol transport and promoting pro-inflammatory cytokine production. PLoS One 2014; 9:e94997.
101. Tian GP, et al: MicroRNA-467b targets LPL gene in RAW 264.7 macrophages and attenuates lipid accumulation and proinflammatory cytokine secretion. Biochimie 2012; 94: 2749-2755.
102. Tian GP, et al: The effects of miR-467b on lipoprotein lipase (LPL) expression, pro-inflammatory cytokine, lipid levels and atherosclerotic lesions in apolipoprotein E knockout mice. Biochem Biophys Res Commun 2014; 443: 428-434.
103. Takahashi Y, et al: Expression of miR-146a/b is associated with the Toll-like receptor 4 signal in coronary artery disease: effect of renin-angiotensin system blockade and statins on miRNA-146a/b and Toll-like receptor 4 levels. Clin Sci (Lond) 2010; 119: 395-405.
104. Taganov KD, et al: NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 2006; 103: 12481-12486.
105. Zhang Y, et al: Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell 2010; 39: 133-144.
106. Li J, et al: Microvesicle-mediated transfer of microRNA-150 from monocytes to endothelial cells promotes angiogenesis. J Biol Chem 2013; 288: 23586-23596.
107. Hoekstra M, et al: The peripheral blood mononuclear cell microRNA signature of coronary artery disease. Biochem Biophys Res Commun 2010; 394: 792-797.
108. Fichtlscherer S, et al: Circulating micro-RNAs in patients with coronary artery disease. Circ Res 2010; 107: 677-684.
109. Ai J, et al: Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem Biophys Res Commun 2010; 391: 73-77.
110. Wang GK, et al: Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 2010; 31: 659-666.
111. Nabialek E, et al: Circulating microRNAs (miR-423-5p, miR-208a and miR-1) in acute myocardial infarction and stable coronary heart disease. Minerva Cardioangiol 2013; 61: 627-637.
112. Jiang Y, et al: Peripheral blood miRNAs as a biomarker for chronic cardiovascular diseases. Sci Rep 2014; 4: 5026.
113. Peng H, et al: Urinary miR-29 correlates with albuminuria and carotid intima-media thickness in type 2 diabetes patients. PLoS One 2013; 8:e82607.
114. Long G, et al: Circulating miR-30a, miR-126 and let-7b as biomarker for ischemic stroke in humans. BMC Neurol 2013; 13: 178.
115. Tsai PC, et al: Serum microRNA-21 and microRNA-221 as potential biomarkers for cerebrovascular disease. J Vasc Res 2013; 50: 346-354.
116. Santovito D, et al: Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients. Expert Opin Ther Targets 2013; 17: 217-223.
117. Weber C, Schober A, Zernecke A: Micro-RNAs in arterial remodelling, inflammation and atherosclerosis. Curr Drug Targets 2010; 11: 950-956.
118. Weber JA, et al: The microRNA spectrum in 12 body fluids. Clin Chem 2010; 56: 1733-1741.
119. Laterza OF, et al: Plasma microRNAs as sensitive and specific biomarkers of tissue injury. Clin Chem 2009; 55: 1977-1983.
120. Wang K, et al: Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci U S A 2009; 106: 4402-4407.
121. Kosaka N, Iguchi H, Ochiya T: Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci 2010; 101: 2087-2092.
122. Dimmeler S, Zeiher AM: Circulating microRNAs: novel biomarkers for cardiovascular diseases? Eur Heart J 2010; 31: 2705-2707.
123. Raitoharju E, Oksala N, Lehtimaki T: MicroRNAs in the atherosclerotic plaque. Clin Chem 2013; 59: 1708-1721.
124. Peng Y, et al: MicroRNAs: emerging roles in adipogenesis and obesity. Cell Signal 2014; 26: 1888-1896.
125. Gebert LF, et al: Miravirsen (SPC3649) can inhibit the biogenesis of miR-122. Nucleic Acids Res 2014; 42: 609-621.